Remdesivir

Veklury

SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor

NADAC/unit N/A

No Shortage

Covered Lives

Market Intelligence

2024-10-09 Class I Recall: Gilead Sciences, Inc.

Generic Manufacturers

GILEAD SCIENCES INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Remdesivir drfinder.aiFind doctors who prescribe Remdesivir rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Remdesivir

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.